News|Articles|February 10, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

  • PTSM: Pharmaceutical Technology Sourcing and Management-03-02-2016
  • Volume 11
  • Issue 3

PBOA Adds Members and Trustees

3M Drug Delivery Systems, Ei Solutionworks, IDT Biologika join CMO/CDMO association

The Pharma & Biopharma Outsourcing Association (PBOA) announced new member companies, as well as new members of its Board of Trustees in a Feb.10, 2015 press release.

IDT Biologika and Ei SolutionWorks joined the PBOA as general members; 3M Drug Delivery Systems (DDS) joined as a sustaining member. Diego Romeu, manufacturing and supply chain director at 3M DDS, was also voted to a three-year term on the board of trustees, along with Rajan Puri, director of business development at Therapure, and Lee Karras, CEO of Halo Pharmaceutical.

“As we continue our mission to represent the CMO/CDMO industry before FDA, Congress and other stakeholders, it’s critical that we increase our membership and provide a true voice for our industry,” said Gil Roth, President of the PBOA. “We’ve been successful in bringing the CMO/CDMO perspective to issues such as GDUFA, Quality Metrics, and serialization, and we’re delighted to bring in new member companies and add fresh points of view to our Board of Trustees.”

Source: Pharma & Biopharma Outsourcing Association

 

 


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.